Oramed Pharmaceuticals
ORMP
$2.30
Share price
-1.29%
Change (1 day)
-36.64%
Change (1 year)
Categories
Oramed Pharmaceuticals (ORMP) - Net assets
Net assets on the balance sheet as of December 2023 : $0.16 B
According to Oramed Pharmaceuticals's latest financial reports the company has $0.16 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Oramed Pharmaceuticals - Net assets on balance sheet (from 2005 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $0.16 B | 7.76% |
| 2022-12-31 | $0.15 B | |
| 2021-08-31 | $0.11 B | 254.38% |
| 2020-08-31 | $32.87 M | 69.54% |
| 2019-08-31 | $19.39 M | -37.67% |
| 2018-08-31 | $31.11 M | 61.72% |
| 2017-08-31 | $19.23 M | -26.54% |
| 2016-08-31 | $26.19 M | 5.49% |
| 2015-08-31 | $24.82 M | 19.41% |
| 2014-08-31 | $20.79 M | 155.73% |
| 2013-08-31 | $8.13 M | 115.22% |
| 2012-08-31 | $3.77 M | 1.45% |
| 2011-08-31 | $3.72 M | 348.52% |
| 2010-08-31 | $0.83 M | -69.77% |
| 2009-08-31 | $2.74 M | -40.21% |
| 2008-08-31 | $4.59 M | 795.33% |
| 2007-08-31 | $0.51 M | -218.55% |
| 2006-08-31 | $-0.44 M | 865.72% |
| 2005-08-31 | $-0.05 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Novo Nordisk NVO | $14.31 B | 8,687.12% | 🇩🇰 Denmark |
 Sanofi SNY | $82.20 B | 50,364.66% | 🇫🇷 France |
 Ultragenyx RARE | $0.27 B | 69.08% | 🇺🇸 USA |
 Lexicon Pharmaceuticals
LXRX | $93.11 M | -42.84% | 🇺🇸 USA |
 Compugen CGEN | $65.55 M | -59.75% | 🇮🇱 Israel |